Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 216.70
+0.85 (0.39%)
At close: Mar 5, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 22.92 billion as of March 5, 2026. Its market cap has increased by 51.56% in one year.
Market Cap
22.92B
Enterprise Value
21.80B
Revenue
8.68B
Ranking
n/a
PE Ratio
21.26
Stock Price
216.70
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 22.92B, an increase of 227,960.18%. That is a compound annual growth rate of 37.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 22.83B | 32.02% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 28.24B |
| Hikal | 23.72B |
| Unichem Laboratories | 23.27B |
| Morepen Laboratories | 22.84B |
| Novartis India | 22.72B |
| Shukra Pharmaceuticals | 17.16B |
| Amrutanjan Health Care | 16.78B |
| Kwality Pharmaceuticals | 15.71B |